Nephro protective infusion solutions
OwnerHagen Bertermanninventor
Life of this patent
Estimating the term…
Abstract
The invention herein is a method of protecting against renal damage in a patient receiving carboplatin, cyclosporine A or cisplatin comprising administering to said patient the following mixture of amino acids consisting of glycine, L-alanine, L-serine, L-threonine, L-valine, L-leucine, L-isoleucine and L-proline.
Claims8
Method of protecting a patient from renal damage caused by nephrotoxic effects of a cancer chemotherapeutic or immunosuppressant agent comprising administering intravenously to the patient in association with the cancer chemotherapeutic agent or immunosuppressant agent selected from the group consisting of carboplatin, cyclosporine A and cisplatin a pharmaceutically acceptable solution containing a nephroprotective amount of the following mixture of amino acids consisting of
- 9 to 11 grams/liter of glycine,
- 12 to 17 grams/liter of L-alanine,
- 10 to 18 grams/liter of L-serine,
- 2 to 5 grams/liter of L-threonine,
- 5 to 10 grams/liter of L-valine,
- 6 to 10 grams/liter of L-valine,
- 2 to 4 grams/liter of L-isoleucine, and
- 6 to 12 grams/liter of L-proline.
Dependencies are inferred from the claim text.